SG
RKDA icon

StoneX Group’s Arcadia Biosciences RKDA Stock Holding History

StoneX Group’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Buy
+13,682
New +$14.2K ﹤0.01% 1355
2022
Q3 		– Sell
-329
Closed -$13.1K – 697
2022
Q2 		$13.1K Buy
+329
New +$15.1K ﹤0.01% 659

Other funds holding RKDA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BWM
Bullock Wealth Management Bloomington, Indiana $231M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

StoneX Group's RKDA Position: Q2 2026 in Review

StoneX Group opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 13,682 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #1355 among its holdings. This is a return to the name: StoneX Group previously reported a position in RKDA as recently as Q2 2022.

StoneX Group first reported a position in RKDA in Q2 2022 and has held it in 2 quarters since. The position peaked at $13.1K in Q2 2022. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • StoneX Group held 13,682 shares of Arcadia Biosciences worth $11.3K as of Q2 2026.
  • Arcadia Biosciences was a new StoneX Group position in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1355 holding.
  • StoneX Group first reported a position in Arcadia Biosciences in Q2 2022 and has held it in 2 quarters since.
  • StoneX Group's Arcadia Biosciences position peaked at $13.1K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.